|
|
|
|
|
|
|
||
| ||||||||||||||||||||||||||
Index of Online Supplemental Material for
J. Exp. Med. 10.1084/jem.20031234
Snyder et al. • Table S1 Sequences of oligonucleotide primers used in this project.
• Table S2 Spleen weights and numbers of nucleated cells in spleens and lymph nodes of transfer recipients at day 10.
• Table S3 Activation of B cells in
Tg mice that received various numbers of CA30 T cells.
• Table S4 Isotypes of antichromatin Ab in the sera of recipient mice.
• Figure S1 Tg expression and allelic exclusion in CA30 TCR Tg mice.
• Figure S2 IL-2 production by stimulated CA30 T cells.
• Figure S3 Increased frequencies of V
2-expressing cells among CD4+ T cells of double Tg mice (CA30/
• Figure S4 IgG and antichromatin titers in recipients of CA30 cells.
• Figure S5 Kidney pathology in CA30 cell recipients.
| ||||||||||||||||||||||||||
| TABLE OF CONTENTS |
|
